38 related articles for article (PubMed ID: 22350136)
1. Study of the diagnostic efficiency of anti-ZnT8 autoantibodies for type 1 diabetes in pediatric patients.
Fuentes-Cantero S; González-Rodríguez C; Rodríguez-Chacón C; Galvan-Toribio R; Hermosín-Escudero J; Pérez-Pérez A; León-Justel A
Lab Med; 2024 May; 55(3):299-303. PubMed ID: 37658812
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of ZnT8 Antibody in Turkish Children and Adolescents with New Onset Type 1 Diabetes.
Elmaoğulları S; Uçaktürk SA; Elbeg Ş; Döğer E; Tayfun M; Gürbüz F; Bideci A
J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):108-112. PubMed ID: 28943512
[TBL] [Abstract][Full Text] [Related]
3. A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.
Zhang B; Kumar RB; Dai H; Feldman BJ
Nat Med; 2014 Aug; 20(8):948-53. PubMed ID: 25038825
[TBL] [Abstract][Full Text] [Related]
4. Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review.
Watkins RA; Evans-Molina C; Blum JS; DiMeglio LA
Transl Res; 2014 Aug; 164(2):110-21. PubMed ID: 24662515
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and phenotypes of diabetes in children and adolescents in non-European-origin populations in or from Western Pacific region.
James S; Maniam J; Cheung PT; Urakami T; von Oettingen J; Likitmaskul S; Ogle G
World J Clin Pediatr; 2022 Mar; 11(2):173-195. PubMed ID: 35433305
[TBL] [Abstract][Full Text] [Related]
6. Type 1 diabetes and associated autoimmune diseases.
Frommer L; Kahaly GJ
World J Diabetes; 2020 Nov; 11(11):527-539. PubMed ID: 33269064
[TBL] [Abstract][Full Text] [Related]
7. Chemokines in Type 1 Diabetes Mellitus.
Pan X; Kaminga AC; Kinra S; Wen SW; Liu H; Tan X; Liu A
Front Immunol; 2021; 12():690082. PubMed ID: 35242125
[TBL] [Abstract][Full Text] [Related]
8. Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis.
Pan X; Kaminga AC; Wen SW; Liu A
Front Immunol; 2021; 12():622438. PubMed ID: 34054797
[TBL] [Abstract][Full Text] [Related]
9. Novel diabetes autoantibodies and prediction of type 1 diabetes.
Wenzlau JM; Hutton JC
Curr Diab Rep; 2013 Oct; 13(5):608-15. PubMed ID: 23900975
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
11. T1D Autoantibodies: room for improvement?
Yu L; Zhao Z; Steck AK
Curr Opin Endocrinol Diabetes Obes; 2017 Aug; 24(4):285-291. PubMed ID: 28509692
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to CCL3 are of low sensitivity and specificity for the diagnosis of type 1 diabetes.
Huang G; Mo X; Li M; Xiang Y; Li X; Luo S; Zhou Z
Acta Diabetol; 2012 Oct; 49(5):395-9. PubMed ID: 22350136
[TBL] [Abstract][Full Text] [Related]
13. Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosis.
Shehadeh N; Pollack S; Wildbaum G; Zohar Y; Shafat I; Makhoul R; Daod E; Hakim F; Perlman R; Karin N
J Immunol; 2009 Jun; 182(12):8104-9. PubMed ID: 19494336
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
[TBL] [Abstract][Full Text] [Related]
15. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
